Register Login

TWIST BIOSCIENCE CORP (TWST)

Leproust Emily M. 🟡 adjusted position in 55.3K shares (6 derivative) of Twist Bioscience Corp (TWST) at $67.85 ($5.2M) Transaction Date: Apr 21, 2026 | Filing ID: 005005

Full text
Register to leave comments
  • News bot April 23, 2026, 8:05 p.m.

    🔍 Leproust Emily M. (Executive)

    Company: Twist Bioscience Corp (TWST)

    Report Date: 2026-04-21

    Transaction Summary:

    • Total transactions: 11
    • Derivative instruments: 6
    • Holdings reported: 4
    • Total shares acquired: 19,342
    • Total shares sold: 9,671
    • Total shares held: 462,779

    Detailed Transactions and Holdings:

    • Acquired 1,610 shares of Common Stock at $8.82 per share (Direct)
      Date: 2026-04-21 | Code: M | equity_swap_involved: false | shares_owned_after: 860,497.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,610 shares of Common Stock at $65.01 per share (Direct)
      Date: 2026-04-21 | Code: S | equity_swap_involved: false | shares_owned_after: 858,887.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 8,061 shares of Common Stock at $8.82 per share (Direct)
      Date: 2026-04-22 | Code: M | equity_swap_involved: false | shares_owned_after: 866,948.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 7,910 shares of Common Stock at $65.275 per share (Direct)
      Date: 2026-04-22 | Code: S | equity_swap_involved: false | shares_owned_after: 859,038.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 151 shares of Common Stock at $66.0 per share (Direct)
      Date: 2026-04-22 | Code: S | equity_swap_involved: false | shares_owned_after: 858,887.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Acquired 1,610 shares of Employee Stock Option (right to buy) at $8.82 per share (Derivative)
      Date: 2026-04-21 | Code: M | Expires: 2027-09-28 | equity_swap_involved: false | shares_owned_after: 149,269.00 | transaction_form_type: 4 | Footnotes: F9
    • Acquired 8,061 shares of Employee Stock Option (right to buy) at $8.82 per share (Derivative)
      Date: 2026-04-22 | Code: M | Expires: 2027-09-28 | equity_swap_involved: false | shares_owned_after: 141,208.00 | transaction_form_type: 4 | Footnotes: F9
    • Holds 0 shares of Employee Stock Option (right to buy) at $5.95 per share (Derivative)
      Date: 2026-04-21 | Code: H | Expires: 2025-09-28 | Footnotes: F5
    • Holds 0 shares of Employee Stock Option (right to buy) at $26.66 per share (Derivative)
      Date: 2026-04-21 | Code: H | Expires: 2028-11-18 | shares_owned_after: 266,539.00 | Footnotes: F6
    • Holds 0 shares of Employee Stock Option (right to buy) at $23.33 per share (Derivative)
      Date: 2026-04-21 | Code: H | Expires: 2029-10-23 | shares_owned_after: 131,290.00 | Footnotes: F7
    • Holds 64,950 shares of Employee Stock Option (right to buy) at $67.85 per share (Derivative)
      Date: 2026-04-21 | Code: H | Expires: 2030-08-31 | Exercise: 2022-12-19 | shares_owned_after: 64,950.00 | Footnotes: F8

    Footnotes:

    • F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 27, 2025.
    • F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $65.00 to $65.06 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $65.00 to $65.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $66.00 to $66.01 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F5: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
    • F6: 20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
    • F7: 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
    • F8: Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria.
    • F9: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Search

News categories